Twist Bioscience Corp. Stock News

One of these biotech stocks could have more room to run than the other.

One of these biotech stocks could have more room to run than the other.

One of these biotech stocks could have more room to run than the other.

Twist Bioscience Corporation (TWST) has partnered with Artisan Development Labs to jointly develop antibodies against five undisclosed targets

The stock market and bond market remain historically overvalued today, however, the almost all-encompassing bubble has started to break. Learn more here.

Business is booming for these life science businesses, but their stock prices have been slashed to bargain prices.

Business is booming for these life science businesses, but their stock prices have been slashed to bargain-basement prices.

Twist Bioscience Corp (TWST) shares closed 0.2% lower than its previous 52 week low, giving the company a market cap of $3B. The stock is currently down 13.8% year-to-date, down 59.9% over the past 12 months, and up 376.7% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 32.1% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 146.8% The company's stock price performance over the past 12 months lags the peer average by 14.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Twist Bioscience Corp (TWST) shares closed today at 0.2% above its 52 week low of $66.61, giving the company a market cap of $3B. The stock is currently down 13.8% year-to-date, down 59.9% over the past 12 months, and up 376.7% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 0.9% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 2.7. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 146.8% The company's stock price performance over the past 12 months lags the peer average by 14.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

There's a clear path for these stocks to deliver 10x gains by the end of the decade.

Twist Bioscience Co. (NASDAQ:TWST) insider William Banyai sold 25,000 shares of the businesss stock in a transaction on Wednesday, December 15th. The shares were sold at an average price of $85.20, for a total transaction of $2,130,000.00. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. William Banyai [] The post Insider Selling: Twist Bioscience Co. (NASDAQ:TWST) Insider Sells $2,130,000.00 in Stock appeared first on ETF Daily News .

Twist Bioscience Co. (NASDAQ:TWST) insider William Banyai sold 25,000 shares of the businesss stock in a transaction that occurred on Wednesday, December 15th. The shares were sold at an average price of $85.20, for a total value of $2,130,000.00. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC []

Codiak BioSciences (NASDAQ:CDAK) and Twist Bioscience (NASDAQ:TWST) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, valuation, earnings and analyst recommendations. Insider and Institutional Ownership 62.9% of Codiak BioSciences shares are owned by institutional investors. Comparatively, 96.1% []

These stocks have been beaten down in 2021. But their prospects remain bright.

Twist Bioscience Co. (NASDAQ:TWST) insider William Banyai sold 25,000 shares of the firms stock in a transaction on Wednesday, December 15th. The stock was sold at an average price of $85.20, for a total value of $2,130,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through []